Skip to main navigation Skip to search Skip to main content

Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression

  • Carolina Martínez-Ciarpaglini
  • , Rita Barros
  • , Carmelo Caballero
  • , Hugo Boggino
  • , Lorena Alarcón-Molero
  • , B. rbara Peleteiro
  • , Erika Ruiz-García
  • , Edith Fernandez-Figueroa
  • , Roberto Herrera-Goepfert
  • , Consuelo Díaz-Romero
  • , Rui Ferreira
  • , Tessa S. Groen-van Schooten
  • , Cinthia Gauna
  • , Rita Pereira
  • , Daniel Cantero
  • , Horacio Lezcano
  • , Federico Esteso
  • , Juan O´Connor
  • , Arnoldo Riquelme
  • , Gareth I. Owen
  • Marcelo Garrido, Juan Carlos Roa, Fiorella Ruiz-Pace, Ana Vivancos, Marc Diez-García, Maria Alsina, Judit Matito, Agatha Martin, Marina Gómez, Ester Castillo, Maria Vila, João Santos-Antunes, Andreia Costa, Florian Lordick, Judith Farrés, Brenda Palomar-de Lucas, Manuel Cabeza-Segura, Rosanna Villagrasa, Elena Jimenez-Martí, Ana Miralles-Marco, Rodrigo Dienstmann, Sarah Derks, Ceu Figueiredo, Andrés Cervantes, F. tima Carneiro, Tania Fleitas-Kanonnikoff*
*Corresponding author for this work
  • Hospital Clinico Universitario de Valencia
  • University of Porto
  • Unidade Local de Saúde de São João
  • Genpat. Pathology Department
  • Hospital General de Valdepeñas
  • Centro Hospitalar Universitário de São João
  • Instituto Nacional de Cancerologia - Mexico
  • Instituto Nacional de Medicina Genomica
  • Amsterdam UMC - University of Amsterdam
  • Amsterdam UMC
  • Oncode Institute
  • Hospital Central Instituto de Previsiín Social
  • Instituto Alexander Fleming
  • Pontificia Universidad Católica de Chile
  • Universidad Mayor
  • Oncology Data Science
  • Valld`Hebron Institute of Oncology
  • Hospital Universitario de Navarra
  • Leipzig University
  • Anaxomics Biotech SL
  • Centro de Investigación Biomédica en Red de Cáncer

Research output: Contribution to journalArticleAcademicpeer-review

24 Downloads (Pure)

Abstract

Introduction: Gastric cancer (GC) burden is currently evolving with regional differences associated with complex behavioural, environmental, and genetic risk factors. The LEGACy study is a Horizon 2020-funded multi-institutional research project conducted prospectively to provide comprehensive data on the tumour biological characteristics of gastroesophageal cancer from European and LATAM countries. Material and methods: Treatment-naïve advanced gastroesophageal adenocarcinoma patients were prospectively recruited in seven European and LATAM countries. Formalin-fixed paraffin-embedded primary tumour endoscopic biopsy samples were collected and submitted for central morphological and immunohistochemical characterization and TP53 molecular assessment and Helicobacter pylori infection. Results: A total of 259 patients were included in the study: 137 (53%) from LATAM and 122 (47%) from Europe. Significant biological differences were detected between European and LATAM patients. Low representation of chromosomal instability (CIN) and HER2 positive cases were found in LATAM. MUC6 and PD-L1 were more frequently overexpressed in European cases, showing a significant correlation across the entire study population, with this association being especially pronounced in MMRdeficient cases. Both TP53 mutation by next-generation sequencing and p53 immunohistochemical aberrant pattern were linked with features associated with chromosomal instability. No regional differences were observed in H. pylori prevalence or abundance, indicating that the afore mentioned variations cannot be attributed to this factor. Conclusion: Our findings underscore a need for region-specific approaches in gastroesophageal cancer diagnosis and treatment. MUC6 emerges as a putative immune regulator that needs further investigation. Research tailored to the unique biological profiles in different global regions is crucial to effectively address the observed disparities.
Original languageEnglish
Article number103841
Pages (from-to)160-173
Number of pages14
JournalGastric cancer
Volume28
Issue number2
Early online date2025
DOIs
Publication statusPublished - Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biomarkers
  • Europe
  • Gastric cancer
  • Helicobacter pylori
  • LATAM

Fingerprint

Dive into the research topics of 'Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression'. Together they form a unique fingerprint.

Cite this